Literature DB >> 10607922

p53 immunohistochemical expression of Egyptian cervical carcinoma.

H Abd El All1, A Rye, P Duvillard.   

Abstract

Data concerning the expression of p53 in cervical carcinoma, one of the leading cause of death in developing countries, are still confusing. This study was designed to identify p53 in Egyptian cervical carcinoma in an attempt to evaluate its prognostic significance. Eleven chronic cervicitis and 38 invasive carcinoma (31 squamous cell carcinoma (sqcc) and 7 adenocarcinoma, ranging from stage IB to IVB), were stained with the monoclonal antibody anti p53, DO7, using the microwave for antigen retrieval. No immunoreactivity was detected in chronic cervicitis, while nuclear p53 reactivity was detected in all carcinoma and in squamous intra-epithelial lesions (SIL) overlying 8 sqcc. P53 immunohistochemical (IHC) expression was more pronounced in early clinical stages (p=0.007) and in adenocarcinoma compared to sqcc (p=0.015). A positive correlation was present between p53 and heat shock protein 70 (hsp70) expressions (p=0.005). No correlation could be found between p53 expression and tumor infiltrating lymphocytes, the presence or absence of either schistosomiasis or HPV infections. It can be concluded, that in the Egyptian population, p53 immunoreactivity appears to be an early event in cervical neoplasm, and seems to play an important role together with other cell regulatory proteins in the process of carcinogenesis, which could be different between sqcc and adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607922     DOI: 10.1053/paor.1999.0134

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

Review 2.  Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour.

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

3.  Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.

Authors:  M Uchiyama; T Iwasaka; N Matsuo; T Hachisuga; M Mori; H Sugimori
Journal:  Gynecol Oncol       Date:  1997-04       Impact factor: 5.482

4.  Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.

Authors:  H Y Ngan; S W Tsao; S S Liu; M Stanley
Journal:  Genitourin Med       Date:  1997-02

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage.

Authors:  R A Woo; K G McLure; S P Lees-Miller; D E Rancourt; P W Lee
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

7.  Carcinoma of the uterine cervix associated with schistosomiasis and induced by human papillomaviruses.

Authors:  P Moubayed; A Ziehe; J Peters; H Mwakyoma; D Schmidt
Journal:  Int J Gynaecol Obstet       Date:  1995-05       Impact factor: 3.561

8.  Gain of function mutations in p53.

Authors:  D Dittmer; S Pati; G Zambetti; S Chu; A K Teresky; M Moore; C Finlay; A J Levine
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

9.  Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.

Authors:  R Holm; H Skomedal; A Helland; G Kristensen; A L Børresen; J M Nesland
Journal:  J Pathol       Date:  1993-01       Impact factor: 7.996

10.  Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.

Authors:  H A Lambkin; C M Mothersill; P Kelehan
Journal:  J Pathol       Date:  1994-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.